Emerging Markets Earnings Roundup: Bayer And Merck (Part 3)
This article was originally published in PharmAsia News
Executive Summary
Emerging markets were a mixed picture for Big Pharma in the third quarter, with China the clear leader, but overall key markets continued to see slower growth, which many blamed on the slowdown in the West.